ADNI-related initiatives in Europe. E-ADNI neugrid/outgrid EADC/ADNI harmonization of hippo manual segmentation

Similar documents
HHS Public Access Author manuscript Alzheimers Dement. Author manuscript; available in PMC 2016 February 01.

Marina Boccardi Thomson Reuter Researcher ID: B ORCID ID: Update: May 2014

Curriculum Vitae. Personal information. Work experience. First name / Surname Martina BOCCHETTA

MRI Hippocampal Volume for Enrichment

Changing diagnostic criteria for AD - Impact on Clinical trials

SUPPLEMENTARY INFORMATION In format provided by Frank et al. (JULY 2010)

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

How can the new diagnostic criteria improve patient selection for DM therapy trials

Neuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens

Harvard Medical School Curriculum Vitae

Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

ORIGINAL CONTRIBUTION. Application of Automated Medial Temporal Lobe Atrophy Scale to Alzheimer Disease

Concept paper on no need for revision of the guideline on medicinal products for the treatment of Alzheimer's disease and other dementias

ADNI PET CORE. Boston April Bill Jagust, Suzanne Baker, Bob Koeppe, Eric Reiman, Kewei Chen, Chet Mathis, Julie Price

WWADNI MRI Core Boston July 2013

Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D.

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer s disease

TOWARD EFFECTIVE ALZHEIMER S THERAPY: PROGRESS AND COLLABORATION. Paul S. Aisen, MD Department of Neurosciences University of California, San Diego

Curriculum Vitae. Education 2007 B.Mus.A. Piano Performance University of Western Ontario

Fully-automated volumetric MRI with normative ranges: Translation to clinical practice

Alzheimer disease (AD) is the most common form of dementia

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

Mild cognitive impairment beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

Multi-template approaches for segmenting the hippocampus: the case of the SACHA software

Tammie Benzinger, MD, PhD

Visual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London

G B Frisoni, P h Scheltens, S Galluzzi, F M Nobili, N C Fox, P H Robert, H Soininen, L-O Wahlund, G Waldemar, E Salmon ...

Normal Aging of the brain

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Neuroimaging strutturale nello studio delle malattie psichiatriche Marina Boccardi LENITEM (Laboratory of Epidemiology, Neuroimaging & Telemedicine)

Automatic pathology classification using a single feature machine learning - support vector machines

Neuroimaging has traditionnally

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence

Brain imaging for the diagnosis of people with suspected dementia

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

The most common cause of dementia is Alzheimer disease.

Early Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods. Christos Davatzikos, Ph.D.

AnalyzePro HIPPOCAMPAL VOLUME ASSESSMENT

Alzheimer disease is the most common cause of dementia in

ADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development

Medial temporal lobe atrophy ratings in a large 75-year-old population-based cohort: gender-corrected and education-corrected normative data

First Scientific Symposium Translational Research in Alzheimer. Paris - September 18, 2009 Collège de France

Imaging of Alzheimer s Disease: State of the Art

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

General introduction

Arg-ADNI. Gustavo E. Sevlever, Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, Ricardo F. Allegri(*) and Arg-ADNI group.

review of existing studies on ASL in dementia Marion Smits, MD PhD

Advances in Alzheimer s diagnosis; implications for clinical practice. Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017

Creating three dimensional models of Alzheimer s disease

HIPPOCAMPAL VOLUME ASSESSMENT. Using Analyze

Neuro degenerative PET image from FDG, amyloid to Tau

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Dementia, Cognitive Aging Services and Support

Issues to Consider in the Clinical Evaluation and Development of Drugs for Alzheimer s Disease. The University of Tokyo Hospital

T1-weighted Axial Visual Rating Scale for an Assessment of Medial Temporal Atrophy in Alzheimer s Disease

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Mild Cognitive Impairment (MCI)

Neuroimaging in Dementia

Outline. Facts and figures Action plans Early / correct diagnosis Conclusions

The availability of in vivo biomarkers of Alzheimer

NeuroReport 2011, 22: a Laboratory of Neuro Imaging, Department of Neurology, UCLA School of. Received 9 March 2011 accepted 13 March 2011

Implementation of fully automated immunoassays for CSF Aβ 1-42, t-tau and p-tau 181 in the Alzheimer s Disease Neuroimaging Initiative

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Disclosure Statement

Molecular Imaging Heterogeneity of Clinically Defined AD

Morphometric MRI Analysis of the Parahippocampal Region in Temporal Lobe Epilepsy

North Savo District Hospital, Iisalmi (Finland) Resident in Neurology, Dept. of Neurology. Kuopio University Hospital, Kuopio (Finland)

Characterizing Anatomical Variability And Alzheimer s Disease Related Cortical Thinning in the Medial Temporal Lobe

Assessing Brain Volumes Using MorphoBox Prototype

Stephen Salloway, M.D., M.S. Disclosure of Interest

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

NIH Public Access Author Manuscript Neuroimaging Clin N Am. Author manuscript; available in PMC 2008 May 12.

Piramal Imaging to Present New Research in PET Imaging at Society of Nuclear Medicine and Molecular Imaging 2017 Annual Meeting

Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos,

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Frisoni 1. LENITEM (Laboratory of Epidemiology, Neuroimaging and Telemedicine) IRCCS S. Giovanni di Dio Fatebenefratelli Brescia, Italy;

Regulatory Challenges across Dementia Subtypes European View

Physiological Markers of Pharmacoresistant Epilepsy December 2, 2011

European Prevention of Alzheimer s Dementia (EPAD)

NIH Public Access Author Manuscript Neuroreport. Author manuscript; available in PMC 2012 June 11.

HOMOTAURINE INVESTIGATIONAL SUMMARY

PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans

Use of Structural Magnetic Resonance Imaging to Predict Who Will Get Alzheimer s Disease

Positioning. > MEMENTO is a large observational study enrolling patients at an. Data first availability for project analyses

MR Differential Diagnosis of Normal-Pressure Hydrocephalus and Alzheimer Disease: Significance of Perihippocampal Fissures

Mild Cognitive Impairment Symposium January 19 and 20, 2013

Automatic thalamus and hippocampus segmentation from MP2RAGE: comparison of publicly available methods and implications for DTI quantification

Original Article An MRI study of age-related changes in the dimensions related temporal lobe

Cognitive ageing and dementia: The Whitehall II Study

CONSENSUS STATEMENT ON DEMENTIA EDUCATION AND TRAINING IN EUROPE

A Harmonized Segmentation Protocol for Hippocampal and Parahippocampal Subregions: Why Do We Need One and What Are the Key Goals?

FINAL AGENDA Administrators Meeting

Submitted to NeuroImage: December 3, 2007 Revised Version submitted: February 9, nd Revision submitted: May 26, 2008

On cognitive performance as endpoint in clinical trials Ben Schmand

A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing.

NeuroImage 45 (2009) Contents lists available at ScienceDirect. NeuroImage. journal homepage:

Transcription:

ADNI-related initiatives in Europe E-ADNI neugrid/outgrid EADC/ADNI harmonization of hippo manual segmentation

Pharma-Cog AIM: To develop new markers homologous in animal and humans sensitive to symptomatic effects and disease modification Development of markers in ANIMALS Development of markers in HUMANS

neugrid and outgrid: THE CONCEPT

FP7 outgrid A Worldwide e-infrastructure for Computational Neuroscientists Access to large image datasets Image analysis algorithms Grid-based high performance computing Image analysis algorithms Grid-based high performance computing Home to world largest image dataset on Alzheimer s Image analysis algorithms Friendly Pipeline Interface Centralized high performance computing

neugrid/outgrid Agreement w/ A Toga and A Evans to progress towards integration of the three infrastructures. A proof-of-concept challenge will be done by the end of 2010 (any source-any sink)

CSF total tau Alzheimer THE CONCEPT Hippocampal volume as a diagnostic marker Structure: MR hippo volumetry Function: FDG PET Amyloid deposits: PET Biochemistry: CSF tau/abeta Normal CSF Abeta42 Dubois, Feldman et al., Lancet Neurol 2007

THE CONCEPT The effect of segmentation protocols on hippocampal volume Ref. Med border Lat border Watson et al. Zipursk y et al. Mesial edge of temporal lobe Regional outline at choroidal fissure Temp horn of lat ventr Not mentioned Inf border Incl subicular complex & uncal cleft w/ border separating subicular complex from parahippo gyrus The interface of hippocampal tissue and parahippocampal gyrus white matter Norm. hippo vol (cm 3 ) Left Right 4.903 5.264 1.990 2.070 Geuze et al., Mol Psychiatry 2005;10:147-59

THE CONCEPT Hippocampal volume as an outcome measure in trials of disease modifiers Drug Study Effect Segment. method Ref Tramiprosate Alphase 68% (100 mg) 120% (150 mg) Atorvastatin ADCLT CHV* mm³ -134 174 vs -583 354 p>.05 Not mentioned Manual protocol Insausti et al., 1998 AJNR; Machulda et al., 2001, Neuroimage Gauthier et al., JNHA 2009 Sparks et.a,l CCJM,2008 LEADe significant at p<.05 MIDAS (semiautomated) Jones et al., Alz&Dem 2008 Feldman et al., Neurology 2010 AN1792 CHV* % 3.78 2.63 vs 2.86 3.19 p = 0.124 Manual protocol Watson et al., 1992, Neurology Fox N et al., Neurology, 2005 Xaliproden Sanofi- Aventis Trials significant atrophy Not mentioned From Vellas B et al. (Review), Lancet Neurol.,2008 Donepezil CHV* % -6.14 3.49vs - 4.50 2.28 p= 0.07 ε4 carriers only Manual protocol Jack et al., 1989;Radiology Jack et al., 2004; Neurology Jack CR et al., Neurobiol. Aging, 2008

BACKGROUND Hippocampal volume (manual segmentation) gold standard for automated segmentation algorithm Morey et al., NeuroImage 2009

AIMS To Harmonize Available Protocols for Manual Hippocampal Segmentation To Test the Validity of the Harmonized Protocol

AUTHORS OF HIPPO PROTOCOLS Bartzokis G, et al. Psychiatry Res 1998;82:11-24 Convit A, et al. Neurobiol Aging 1997;18:131-8 Haller JW, et al. Radiology 1997;202:504-10 Jack CR Jr. Epilepsia 1994;35 - Suppl 6:S21-9 Killiany RJ, et al. Arch Neurol 1993;50:949-54 Lehéricy S, et al. Am J Neuroradiol 1994;15:929-37 Malykhin NV, et al. Psychiatry Res 2007;155:155-65 Pantel J, et al. Hippocampus 2000;10:752-8 Pruessner JC, et al. Cereb Cortex 2000;10:433-42 Soininen HS, et al. Neurology 1994;44:1660-8

THE WORKGROUP EADC F Barkhof/P Scheltens B Dubois/S Leherici N Fox/J Barnes GB Frisoni H Hampel/J Pantel A Simmons H Soininen S Teipel LO Wahlund Amsterdam Paris London Brescia Frankfurt London Kuopio Rostock Stockholm

THE WORKGROUP ADNI CR Jack Jr Rochester, MN G Barzokis UCLA, CA D Bennet Chicago, IL J Csernansky NorthW U, WA C DeCarli UC Davis, CA M De Leon New York, NY J Kaye Portland, OR R Killiany Boston USM, MA PM Thompson LoNI, UCLA, CA M Weiner/S Mueller UCSF/VAMC

THE WORKGROUP other relevant hippo experts R Camicioli J O Brien J Pruessner Univ Alberta, Canada NewCastle, UK McGill, QC, Canada

THE WORKGROUP Boards EADC-ADNI P.I.s B Vellas B Winblad M Weiner Toulouse, France Stockholm, Sweden UCSF, US Population-based studies M Breteler / T Den Heijer P Sachdev/ JJ Maller L Launer W Jagust Rotterdam Scan Study PATH through life NIA Bethesda Berkeley

THE WORKGROUP Boards Statistical Board S Duchesne L Collins P Pasqualetti Clinical Advisor PJ Visser Netherlands Laval Univ, Canada MNI, McGill, Montreal AFaR, Rome Maastricht, The Dissemination/Education G Waldemar Copenhagen, Denmark

THE WORKGROUP Personnel in Brescia Marina Boccardi Rossana Ganzola Enrica Cavedo Michela Pievani Anna Caroli Alberto Redolfi psychologist, PhD psychologist psychologist mathematician mathematician bioinformaticist

PRELIMINARY RESULTS

EADC-ADNI Harmonization of Hippocampal Volumetry A meeting has been hold in Toronto yesterday (co-chair Cliff jack) to update. Oral communication will be given at Imaging preconference at ICAD 2010. Featured Research Symposium of the AIC will take place at ICAD 2010 www.hippocampal-protocol.net